Six years after the COVID-19 pandemic began, doctors are still treating long COVID patients with complex symptoms and unknown ...

The 2025 Interdisciplinary Research Grant (IRG) for Convergent Innovation is designed to contribute to CUNY’s goal of amplifying the quantity and quality of engaged public impact research and ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

Cavities at protein-protein interaction interfaces are often considered "undruggable" because their shallow or large geometries hinder the stable ...

Cavities at protein-protein interaction interfaces are often considered "undruggable" because their shallow or large geometries hinder the stable binding by small molecules. A study published ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

ACE2 (angiotensin-converting enzyme 2) is a monocarboxypeptidase that cleaves Ang II (angiotensin II) among other substrates. ACE2 is present in the cell membrane of many organs, most abundantly in ...

This manuscript presents a valuable antiviral approach using an engineered ACE2-Fc fusion protein that demonstrates broad-spectrum neutralization capacity against SARS-CoV-2 variants and achieves ...

Frank Lampard celebrates victory this season Mike Hewitt/Getty Images The Coventry Building Society Arena has never seen top-flight football in its 20-year history, but it is getting used to the sight ...